Upholding Justice Manmohan Singh's order of January 2015, the division bench of Badar Durrez Ahmed and Sanjeev Sachdeva, JJ. of the Delhi High Court today restrained Cipla from infringing Novartis' patent on its drug Indacaterol - marketed under the name "Onbrez".
Onbrez is a respiratory drug, which provides relief to persons suffering from Chronic Obstructive Pulmonary Disease (COPD). It is a drug manufactured by the Swiss company in Switzerland and imported into India by Lupin . . .
With a premium account you get:
- One year of unrestrcited access to previous interviews, columns and articles
- One year access to all archival material
- Access to all Bar & Bench reports